Ciltistotug
Based on 1 Customer Validation
Ciltistotug is a monoclonal antibody targeting human CD40 (TNFRSF5). Ciltistotug activates immune cells after binding to CD40, exerting immunostimulatory and antitumor activities. Ciltistotug is promising for research of cancer immunotherapy.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 95.376%
- No. CAS: 3014361-59-9
- Peso molecular:144.954 kDa
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas TNF Receptor
More
Actividad biológica
Descripciòn
Isotype
Human IgG2 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
CD40
Gene ID
Accession
P25942-1
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG2-kappa
Aplicación
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized HY-P73499A CD40 Protein, Human (HEK293, His) can bind Ciltistotug. The EC50 for this effect is 23.16 ng/mL.
Chemical Information
-
No. CAS 3014361-59-9
-
Appearance Liquid
-
Peso molecular 144.954 kDa
-
Color Colorless to light yellow
-
SMILES
[Ciltistotug]
-
Synonyms
YH003
-
Envío
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
Ficha de datos (254 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)